BRPI0510150A - processo para preparação de derivados de 1,4-difenilacetidinonas - Google Patents

processo para preparação de derivados de 1,4-difenilacetidinonas

Info

Publication number
BRPI0510150A
BRPI0510150A BRPI0510150-6A BRPI0510150A BRPI0510150A BR PI0510150 A BRPI0510150 A BR PI0510150A BR PI0510150 A BRPI0510150 A BR PI0510150A BR PI0510150 A BRPI0510150 A BR PI0510150A
Authority
BR
Brazil
Prior art keywords
sym
derivatives
preparing
alkyl
coo
Prior art date
Application number
BRPI0510150-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Andreas Lindenschmidt
David William Will
Gerhard Jaehne
Theodor Andreas Wollmann
Wendelin Frick
Bernd Junker
David Rigal
Guenter Billen
Heiner Jendralla
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200410025071 external-priority patent/DE102004025071B4/de
Priority claimed from DE102005010770A external-priority patent/DE102005010770A1/de
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of BRPI0510150A publication Critical patent/BRPI0510150A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0510150-6A 2004-05-21 2005-05-20 processo para preparação de derivados de 1,4-difenilacetidinonas BRPI0510150A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE200410025071 DE102004025071B4 (de) 2004-05-21 2004-05-21 Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
DE102005010770A DE102005010770A1 (de) 2005-03-09 2005-03-09 Verfahren zur Herstellung von 1,4-Diphenylazetidinon-Derivaten
PCT/EP2005/005498 WO2005113496A1 (de) 2004-05-21 2005-05-20 Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten

Publications (1)

Publication Number Publication Date
BRPI0510150A true BRPI0510150A (pt) 2007-10-02

Family

ID=37561403

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510150-6A BRPI0510150A (pt) 2004-05-21 2005-05-20 processo para preparação de derivados de 1,4-difenilacetidinonas

Country Status (25)

Country Link
US (1) US7488818B2 (https=)
EP (1) EP1756049B1 (https=)
JP (1) JP2007538042A (https=)
KR (1) KR20070027554A (https=)
AR (1) AR049184A1 (https=)
AT (1) ATE376997T1 (https=)
AU (1) AU2005245124A1 (https=)
BR (1) BRPI0510150A (https=)
CA (1) CA2567149A1 (https=)
CY (1) CY1107425T1 (https=)
DE (1) DE502005001841D1 (https=)
DK (1) DK1756049T3 (https=)
ES (1) ES2294712T3 (https=)
HR (1) HRP20070570T3 (https=)
IL (1) IL178991A0 (https=)
MA (1) MA28635B1 (https=)
MX (1) MXPA06013456A (https=)
NZ (1) NZ551413A (https=)
PL (1) PL1756049T3 (https=)
PT (1) PT1756049E (https=)
RS (1) RS50539B (https=)
RU (1) RU2380361C2 (https=)
TW (1) TW200611896A (https=)
UY (1) UY28912A1 (https=)
WO (1) WO2005113496A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
CN100471835C (zh) * 2003-12-23 2009-03-25 默克公司 抗高胆固醇血症化合物
EP1699759B1 (en) 2003-12-23 2010-10-20 AstraZeneca AB Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
US20090047716A1 (en) * 2007-06-07 2009-02-19 Nurit Perlman Reduction processes for the preparation of ezetimibe
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
WO2011056895A1 (en) * 2009-11-03 2011-05-12 University Of Notre Dame Du Lac Ionic liquids comprising heteraromatic anions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9670237B2 (en) 2011-09-22 2017-06-06 Ut-Battelle, Llc Phosphonium-based ionic liquids and their use in the capture of polluting gases
WO2015048765A1 (en) 2013-09-30 2015-04-02 University Of Notre Dame Du Lac Compounds, complexes, compositions, methods and systems for heating and cooling
US10086331B2 (en) 2013-11-05 2018-10-02 University Of Notre Dame Du Lac Carbon dioxide capture using phase change ionic liquids
JP6803138B2 (ja) * 2014-10-22 2020-12-23 三星エスディアイ株式会社Samsung SDI Co., Ltd. ホスホニウム系化合物、それを含むエポキシ樹脂組成物、およびそれを用いて製造された半導体装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2107548T3 (es) * 1991-07-23 1997-12-01 Schering Corp Compuestos de beta-lactama sustituidos utiles como agentes hipocolesterolemicos y procedimientos para su preparacion.
FI960095L (fi) * 1993-07-09 1996-01-09 Schering Corp Menetelmä atsetidinonien syntetitoimiseksi
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP20030498A2 (en) * 2000-12-21 2005-04-30 Aventis Pharma Deutschland Gmbh Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same

Also Published As

Publication number Publication date
DE502005001841D1 (de) 2007-12-13
EP1756049A1 (de) 2007-02-28
KR20070027554A (ko) 2007-03-09
AR049184A1 (es) 2006-07-05
US20070149776A1 (en) 2007-06-28
TW200611896A (en) 2006-04-16
IL178991A0 (en) 2007-03-08
NZ551413A (en) 2009-07-31
MA28635B1 (fr) 2007-06-01
PT1756049E (pt) 2007-12-17
MXPA06013456A (es) 2007-03-01
WO2005113496A1 (de) 2005-12-01
US7488818B2 (en) 2009-02-10
JP2007538042A (ja) 2007-12-27
PL1756049T3 (pl) 2008-02-29
RU2380361C2 (ru) 2010-01-27
CA2567149A1 (en) 2005-12-01
CY1107425T1 (el) 2013-03-13
RS50539B (sr) 2010-05-07
AU2005245124A1 (en) 2005-12-01
RU2006145444A (ru) 2008-06-27
ES2294712T3 (es) 2008-04-01
EP1756049B1 (de) 2007-10-31
DK1756049T3 (da) 2008-02-25
HRP20070570T3 (en) 2008-01-31
ATE376997T1 (de) 2007-11-15
UY28912A1 (es) 2005-12-30
HK1103296A1 (zh) 2007-12-14

Similar Documents

Publication Publication Date Title
BRPI0510150A (pt) processo para preparação de derivados de 1,4-difenilacetidinonas
BR112012029589A2 (pt) surfatante de olefinas internas sulfonadas para recuperação avançada de petróleo
BR112015017675A2 (pt) processo para a produção de 1, 4, 7, 10 – tetraazaciclododecano-1, 4, 7, 10-ácido tetra acético e complexos do mesmo
BR112015000373A2 (pt) metódo para produzir composto de politiol, composição polimerizável para material ótico e usos dos mesmos
BR112018005284A2 (pt) ácido nucleico interligado guna, método para produzir o mesmo, e composto intermediário
BRPI0408492A (pt) processo para preparar ditioésteres
BRPI0511025A (pt) azinil-imidazoazinas e azinilcarboxamidas
BRPI0713190A2 (pt) método para a preparação de um composto
BRPI0900385A2 (pt) composições de tratamento de poço contendo salmouras de nitrato e método de usar as mesmas
BR112014032198A2 (pt) 1,1'-[[(alquil substituído)imino]bis(alquileno)]bis-ferrocenos e seus usos em ensaios electroquímicos por marcação de substratos de interesse
BR112016008354A2 (pt) processo de preparação de alquilaluminoxanos por meio da reação de alquilalumínio com um álcool alílico substituído da fórmula, produto que pode ser obtido por meio do processo, e, uso do produto
BR112016000968A2 (pt) Processo para a preparação de bifenilanilidas halogenadas
BRPI0511933B8 (pt) derivados de quinazolinona, seu uso e seu processo de preparação, e composição farmacêutica
BR0211766A (pt) N-acetil-d-glucosamina e processo para produção de n-acetil-d-glucosamina
BR112014027620A2 (pt) formulação, uso de uma formulação, processo para fabricar uma formulação, composto, e, processo para a preparação de um composto
BRPI0408160A (pt) processo para o preparo de ésteres do ácido nicotìnico substituìdo
BRPI0809942B8 (pt) processos de preparação de porfirinas, pirrometanos e compostos intermediários
BR0316763A (pt) Compostos de sais sulfÈnicos eficazes em fotoiniciadores catiÈnicos multifuncionais, composição e processo
BRPI0510399A (pt) processo de preparo de derivados n-piperidino-1,5-difenilpirazol-3-carboxamida
BR112012018069A2 (pt) intermediário sintético de composto de oxazol e método para produzir o mesmo
DE602004032024D1 (de) Behandlung hochleistungsfähiger pigmentfarbstoffe mit dispergierenden etheramin-salzen
DE502005003737D1 (de) Leitsalze fur galvanische zellen, deren herstellung und verwendung
BRPI0415223A (pt) processo para a preparação de derivados de aciluréia, sais desses derivados de aciluréia e seu uso como composições praguicidas
BRPI0607049A2 (pt) processo para a procuração de um catalisador para a dessulfuração de correntes de hidrocarboneto
Van Den Bosch et al. Simulation of the substrate cavity dynamics of quercetinase

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.